Brief: Sino Biopharmaceutical Announces Interim Dividend Of HK3 Cents Per Share
13/08/2024 09:37
Aug 13 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* HY PROFIT ATTRIBUTABLE RMB3.02 BILLION VERSUS RMB1.26
BILLION
* HY REVENUE RMB 15.87 BILLION
* PAYMENT OF AN INTERIM DIVIDEND OF HK3 CENTS PER SHARE
* LOOKING TO VAST GLOBAL MARKET TO ACCELERATE ITS INNOVATION
AND
DEVELOPMENT THROUGH GLOBALIZATION
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sino Biopharmaceutical
See all newsBrief: Sino Biopharmaceutical Announces Share Purchase Plan For HK$2 Billion
Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
Brief: Sino Biopharmaceutical Says Zongertinib Approved By NMPA China
GSK to team up with Sino Biopharma for China launch of hepatitis B treatment (updated)
HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up